Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2022-04-26 Capital/Financing Update
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
소액공모공시서류(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Small-Scale Public Offering Disclosure Document' (소액공모공시서류) filed by Nexturn BioScience with the Financial Supervisory Service (FSS) in South Korea. It details a third-party allocation capital increase (유상증자) of 260,756 shares. This document is a formal regulatory filing required for small-scale public offerings (under 1 billion KRW) where a full securities registration statement is not required. It contains specific details on the offering, share rights, and investment risks, fitting the definition of a regulatory filing for capital changes.
2022-04-26 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Nexturn Bio regarding the adjustment of conversion prices for convertible bonds due to a decline in market price. This type of disclosure relates to changes in capital structure and financial instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most appropriate as it covers updates on financing activities and capital structure changes, which includes the adjustment of conversion prices for debt instruments.
2022-04-20 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds due to a decline in market price. This type of disclosure, which impacts the company's capital structure and potential share dilution, is classified under 'Capital/Financing Update' (CAP) as it pertains to financing instruments and their terms.
2022-04-19 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by a major shareholder (Korea Securities Finance Corp) in Nexturn Bioscience. This type of filing is a mandatory regulatory disclosure regarding significant shareholding thresholds and does not fit into specific categories like M&A, dividends, or earnings releases. Therefore, it is classified as a Regulatory Filing (RNS).
2022-04-11 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Nexturn Bioscience regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment of payment dates, share issuance schedules, and pricing methods for a third-party allocation capital increase. This falls under the category of announcements regarding new share issues or capital changes.
2022-04-11 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds due to a decline in market price. This type of disclosure is a standard capital structure update related to financing instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate classification for adjustments to convertible security terms.
2022-04-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.